We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.3B
AUM Growth
+$783M
(+4.2%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
1,342
New
146
Increased
332
Reduced
638
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$37.2M |
| 2 |
Progressive
PGR
|
+$34.8M |
| 3 |
Northrop Grumman
NOC
|
+$24.6M |
| 4 |
Revvity
RVTY
|
+$24.1M |
| 5 |
Carrier Global
CARR
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.9M |
| 2 |
Fortinet
FTNT
|
+$36.2M |
| 3 |
Ameriprise Financial
AMP
|
+$35.9M |
| 4 |
Cadence Design Systems
CDNS
|
+$31M |
| 5 |
Broadstone Net Lease
BNL
|
+$30.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Healthcare | 12.4% |
| 3 | Financials | 11.64% |
| 4 | Consumer Discretionary | 9.19% |
| 5 | Industrials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Monster Beverage
MNST
$91.4B
| $49.8M | 0.26% |
1,091,388
-289,496
| -21% | -$13.6M |
|
102
Regeneron Pharmaceuticals
REGN
$68.8B
| $49.7M | 0.26% |
89,028
-2,313
| -3% | -$1.17M |
|
103
NVIDIA
NVDA
$5.01T
| $48.7M | 0.25% |
2,432,880
+40,680
| +2% | +$652K |
|
104
Booz Allen Hamilton
BAH
$8.7B
| $47.2M | 0.24% |
553,904
+158,971
| +40% | +$13.4M |
|
105
Texas Instruments
TXN
$255B
| $46.9M | 0.24% |
244,033
-5,543
| -2% | -$1.04M |
|
106
Verizon
VZ
$194B
| $46.4M | 0.24% |
827,462
-8,140
| -1% | -$467K |
|
107
Ulta Beauty
ULTA
$20.4B
| $45.5M | 0.24% |
131,663
-1,503
| -1% | -$493K |
|
108
Dow Inc
DOW
$21.6B
| $44.8M | 0.23% |
708,088
+10,521
| +2% | +$695K |
|
109
Vanguard Total Stock Market ETF
VTI
$654B
| $44.3M | 0.23% |
198,886
+8,520
| +4% | +$1.85M |
|
110
Skyworks Solutions
SWKS
$9.06B
| $43.2M | 0.22% |
225,488
+7,784
| +4% | +$1.38M |
|
111
Lam Research
LRCX
$382B
| $43M | 0.22% |
660,150
-131,670
| -17% | -$8.31M |
|
112
Coca-Cola
KO
$354B
| $42.8M | 0.22% |
790,808
-3,379
| -0.4% | -$184K |
|
113
Visa
V
$677B
| $42.7M | 0.22% |
182,715
-59,318
| -25% | -$13.6M |
|
114
Agilent Technologies
A
$39.1B
| $42.4M | 0.22% |
286,615
-7,437
| -3% | -$1.01M |
|
115
Medtronic
MDT
$107B
| $42.4M | 0.22% |
341,215
-306
| -0.1% | -$38.4K |
|
116
Quanta Services
PWR
$93.9B
| $42.1M | 0.22% |
464,637
+111,389
| +32% | +$10.5M |
|
117
Cognizant
CTSH
$21.5B
| $41.8M | 0.22% |
602,868
-264,249
| -30% | -$19.7M |
|
118
Dollar Tree
DLTR
$23.1B
| $41.7M | 0.22% |
419,208
-27,881
| -6% | -$3.03M |
|
119
Kroger
KR
$34.8B
| $41.6M | 0.22% |
1,086,569
-181,158
| -14% | -$6.82M |
|
120
Baxter International
BAX
$11.6B
| $41.5M | 0.21% |
515,175
-8,122
| -2% | -$681K |
|
121
Church & Dwight Co
CHD
$23.1B
| $41.3M | 0.21% |
485,185
+284
| +0.1% | +$24.6K |
|
122
Altria Group
MO
$122B
| $40.8M | 0.21% |
854,798
-24,840
| -3% | -$1.22M |
|
123
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
| $40.7M | 0.21% |
552,481
-84,165
| -13% | -$6.08M |
|
124
KLA
KLAC
$275B
| $39.5M | 0.2% |
1,216,910
-28,070
| -2% | -$899K |
|
125
Edwards Lifesciences
EW
$47.6B
| $39.2M | 0.2% |
378,232
-9,244
| -2% | -$871K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2021 Portfolio in Review
As of Q2 2021, Glenmede Trust held 1,342 positions worth $19.3B, up 4.2% from $18.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2021 filing shows 146 new, 332 increased, 638 reduced and 75 closed positions. Its largest new stake was Virtu Financial: 627,026 shares worth $17.3M. The largest sale was McKesson, an estimated $82.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2021 buy was Virtu Financial: 627,026 shares worth $17.3M.
- Glenmede Trust added most to TJX Companies in Q2 2021, an estimated $37.2M increase.
- Glenmede Trust's biggest Q2 2021 reduction was McKesson, cutting an estimated $82.9M.
- Glenmede Trust fully exited Western Alliance Bancorporation in Q2 2021, selling an estimated $19.5M.
- Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q2 2021.
- Glenmede Trust opened 146 new positions and closed 75 in Q2 2021.
- Glenmede Trust's portfolio value rose 4.2% quarter-over-quarter to $19.3B.
Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.